Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Biochimica Et Biophysica Acta
Eiji FurutaKounosuke Watabe

Abstract

Re-programming of metabolic pathways is a hallmark of physiological changes in cancer cells. The expression of certain genes that directly control the rate of key metabolic pathways including glycolysis, lipogenesis and nucleotide synthesis are drastically altered at different stages of tumor progression. These alterations are generally considered as an adaptation of tumor cells; however, they also contribute to the progression of tumor cells to become more aggressive phenotypes. This review summarizes the recent information about the mechanistic link of these genes to oncogenesis and their potential utility as diagnostic markers as well as for therapeutic targets. We particularly focus on three groups of genes; GLUT1, G6PD, TKTL1 and PGI/AMF in glycolytic pathway, ACLY, ACC1 and FAS in lipogenesis and RRM2, p53R2 and TYMS for nucleotide synthesis. All these genes are highly up-regulated in a variety of tumor cells in cancer patients, and they play active roles in tumor progression rather than expressing merely as a consequence of phenotypic change of the cancer cells. Molecular dissection of their orchestrated networks and understanding the exact mechanism of their expression will provide a window of opportunity to target thes...Continue Reading

References

Jan 5, 1978·Nature·J C WilliamsH P Morris
Feb 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J KoudstaalS H Overdiep
Jan 1, 1991·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·X FilellaA M Ballesta
Jul 16, 1990·Biochemical and Biophysical Research Communications·T YamamotoH Imura
Aug 1, 1988·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·K R HallidayL O Sillerud
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L A LiottaE Schiffmann
Oct 5, 1988·Journal of the National Cancer Institute·R GuirguisL Liotta
Sep 1, 1973·Journal of Neurochemistry·R W HortonH S Bachelard
Oct 24, 1981·Nucleic Acids Research·F Creusot, J K Christman
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·R A GottliebB M Babior
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·Y S AhnP Bannasch
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·F P KuhajdaG R Pasternack
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·H FanJ A Wright
Jan 1, 1997·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·E S PizerF P Kuhajda
Oct 31, 1997·Journal of the American Academy of Dermatology·S C BaerM Younes
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·H FanJ A Wright
Jun 17, 1998·Free Radical Biology & Medicine·W Y Kuo, T K Tang
Jul 9, 1998·Pathology Oncology Research : POR·M Grover-McKayM J Hendrix
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M SakashitaM Kasuga
Jun 29, 2001·Current Opinion in Oncology·C G Leichman

❮ Previous
Next ❯

Citations

Dec 29, 2010·Breast Cancer Research and Treatment·Puspa R PandeyKounosuke Watabe
Sep 16, 2011·Pharmaceutical Research·Emma E RamsayPierre J Dilda
Jul 30, 2010·The Journal of Biological Chemistry·Lars MitschkeKai Tittmann
Nov 10, 2009·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
Jan 13, 2012·Pharmacogenetics and Genomics·Ellen M McDonaghTeri E Klein
Jul 23, 2011·Genes & Cancer·Natalia V OleinikSergey A Krupenko
Sep 1, 2012·World Journal of Biological Chemistry·Feng Zhang, Guangwei Du
Jan 25, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Andrea Morandi, Paola Chiarugi
Nov 15, 2014·Breast Cancer Research and Treatment·S N OnonyeL Pusztai
May 31, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mohammad Aminur RahmanDong M Shin
Nov 1, 2015·Nucleic Acids Research·Pora KimZhongming Zhao
Feb 22, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mohammad Aminur RahmanDong M Shin
Dec 31, 2011·Drug Discovery Today·Neil P Jones, Almut Schulze
Jul 14, 2014·Neoplasia : an International Journal for Oncology Research·Nagireddy PutluriArun Sreekumar
Jun 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zuxuan ShiQingxia Fan
Apr 20, 2011·Journal of Cellular Physiology·Charles E Wenner
Nov 22, 2011·Biotechnology Journal·Woo Suk Ahn, Maciek R Antoniewicz
Oct 19, 2010·Biochimica Et Biophysica Acta·Arnaud ChevrollierGeorges Stepien
Apr 5, 2016·Biochimie·Leesha K GunninkLarry L Louters
Dec 18, 2013·Biochimie·Stephen M GunninkLarry L Louters
Sep 27, 2015·Cellular and Molecular Life Sciences : CMLS·Dominik KrausJochen Winter
Mar 5, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ankit SharmaChandi C Mandal
May 16, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Christian DegenGerhard Jahreis
Aug 8, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xin WangRuitai Fan
Apr 4, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jun OsugiMitsukazu Gotoh
Feb 27, 2014·Biochimica Et Biophysica Acta·Daniele Lettieri BarbatoMaria Rosa Ciriolo
Apr 22, 2016·Breast Cancer Research and Treatment·F MartelE Keating
Jun 15, 2014·Biochimica Et Biophysica Acta·German A Kochetov, Olga N Solovjeva
Mar 8, 2014·Molecular and Biochemical Parasitology·Amaranta Gómez-ArreazaLuisana Avilán

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.